These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14728067)

  • 1. The role of lipids in the development of diabetic microvascular complications: implications for therapy.
    Misra A; Kumar S; Kishore Vikram N; Kumar A
    Am J Cardiovasc Drugs; 2003; 3(5):325-38. PubMed ID: 14728067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy for the treatment of diabetic dyslipidemia.
    Haffner SM
    Diabetes Metab Res Rev; 2003; 19(4):280-7. PubMed ID: 12879405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Statins (HMG-CoA reductase inhibitors)].
    Gotoda T
    Nihon Rinsho; 2006 Nov; 64(11):2113-8. PubMed ID: 17087305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins for diabetic cardiovascular complications.
    Ludwig S; Shen GX
    Curr Vasc Pharmacol; 2006 Jul; 4(3):245-51. PubMed ID: 16842142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of dyslipidemia and effects of statins on nonmacrovascular diseases.
    Baghdasarian SB; Jneid H; Hoogwerf BJ
    Clin Ther; 2004 Mar; 26(3):337-51. PubMed ID: 15110128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering?
    Leiter LA
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl 2():S3-14. PubMed ID: 15953505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid lowering therapy in atherosclerosis.
    Aikawa M; Libby P
    Semin Vasc Med; 2004 Nov; 4(4):357-66. PubMed ID: 15861316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperlipidemia and diabetes mellitus.
    O'Brien T; Nguyen TT; Zimmerman BR
    Mayo Clin Proc; 1998 Oct; 73(10):969-76. PubMed ID: 9787748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipids--Diagnosis and therapy in diabetes mellitus].
    Wascher TC; Paulweber B; Toplak H; Säly CH; Drexel H; Föger B; Hoppichler F
    Wien Klin Wochenschr; 2016 Apr; 128 Suppl 2():S68-70. PubMed ID: 27052223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of atherosclerosis in diabetes: emphasis on treatment for the abnormal lipoprotein metabolism of diabetes.
    Kim DK; Escalante DA; Garber AJ
    Clin Ther; 1993; 15(5):766-78; discussion 765. PubMed ID: 8269443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic dyslipidemia: a case for aggressive intervention in the absence of clinical trial and cost effectiveness data.
    Lewis GF
    Can J Cardiol; 1995 May; 11 Suppl C():24C-28C. PubMed ID: 7750045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipids: diagnosis and therapy in type 2 diabetes].
    Wascher TC; Paulweber B; Toplak H; Saely C; Drexel H
    Wien Klin Wochenschr; 2012 Dec; 124 Suppl 2():28-30. PubMed ID: 23250461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New potentials for 3-hydroxy-3-methyl-glutaryl-coenzymeA reductase inhibitors: Possible applications in retarding diabetic complications.
    Bahrambeigi S; Rahimi M; Yousefi B; Shafiei-Irannejad V
    J Cell Physiol; 2019 Nov; 234(11):19393-19405. PubMed ID: 31004363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations.
    Hamilton-Craig I; Kostner KM; Woodhouse S; Colquhoun D
    Int J Evid Based Healthc; 2012 Sep; 10(3):181-90. PubMed ID: 22925614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do people with diabetes need statins?
    White JR
    Diabetes Educ; 2008; 34(4):664-73. PubMed ID: 18669808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of microvascular and macrovascular complications in diabetes mellitus.
    Maji D
    J Indian Med Assoc; 2004 Aug; 102(8):426, 428, 430 passim. PubMed ID: 15719805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention and remission of diabetic nephropathy].
    Sugimoto T; Nakamura Y; Makino H
    Nihon Rinsho; 2003 Jul; 61(7):1167-71. PubMed ID: 12877079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.